Home>
US Stocks>
Aquestive Therapeutics

Aquestive Therapeutics share price today

(AQST)

Aquestive Therapeutics share price is $3.67 & ₹314.67 as on 3 Jan 2025, 2.30 'hrs' IST

$3.67

▲

0.11

(3.09%)

Market is closed - opens 8 PM, 03 Jan 2025

View live Aquestive Therapeutics share price in Dollar and Rupees. Guide to invest in Aquestive Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Aquestive Therapeutics. Get details on the Indian mutual funds that are investing in Aquestive Therapeutics. Get Analyst recommendations and forecasts along with all the Aquestive Therapeutics's financials.

Aquestive Therapeutics share price movements

Today's Low: $3.56
Today's High: $3.78
$3.67
3.0%
Downside
Day's Volatility :5.82%
Upside
2.91%
52 Weeks Low: $1.98
52 Weeks High: $6.23
$3.67
46.05%
Downside
52 Weeks Volatility :68.22%
Upside
41.09%

Aquestive Therapeutics Returns

Period	Aquestive Therapeutics Inc	Index (Russel 2000)
3 Months	-28.08%	0.0%
6 Months	43.55%	0.0%
1 Year	57.52%	0.0%
3 Years	-12.96%	-21.2%

Aquestive Therapeutics Key Statistics

in dollars & INR

Previous Close	$3.56
Open	$3.6
Today's High	$3.78
Today's Low	$3.56
Market Capitalization	$324.6M
Today's Volume	$2.2M
52 Week High	$6.23
52 Week Low	$1.98
Revenue TTM	$58.9M
EBITDA	$-20.0M
Earnings Per Share (EPS)	$-0.45
Profit Margin	-59.75%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	0.0%

How to invest in Aquestive Therapeutics from India?

It is very easy for Indian residents to invest directly in Aquestive Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Aquestive Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Aquestive Therapeutics or AQST on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Aquestive Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Aquestive Therapeutics shares which would translate to 0.234 fractional shares of Aquestive Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Aquestive Therapeutics, in just a few clicks!

Returns in Aquestive Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

Aquestive Therapeutics investment value today

Current value as on today

₹1,65,364

Returns

₹65,364

(+65.36%)

Returns from Aquestive Therapeutics Stock

₹62,389 (+62.39%)

Dollar Returns

₹2,975 (+2.97%)

Indian investors sentiment towards Aquestive Therapeutics

57%

Period: Oct 4, 2024 to Jan 2, 2025. Change in 30 Days versus previous period

Search volume for Aquestive Therapeutics on INDmoney from India has grown in the last 30 days as on Jan 3, 2025. 57% more investors are searching Aquestive Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Aquestive Therapeutics

Bratton Capital Management, L.P.
10.76%
VR Adviser, LLC
6.09%
BlackRock Inc
5.98%
Vanguard Group Inc
4.68%
Franklin Resources Inc
3.03%
MPM Oncology Impact Management LP
1.97%

Analyst Recommendation on Aquestive Therapeutics

Buy

92%Buy

7%Hold

0%Sell

Based on 14 Wall street analysts offering stock ratings for Aquestive Therapeutics(by analysts ranked 0 to 5 stars)

Based on 14 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Aquestive Therapeutics

What analysts predicted

Upside of 195.19%

Current:

$3.67

Target:

$10.83

Insights on Aquestive Therapeutics

Price Movement
In the last 1 month, AQST stock has moved down by -26.0%
Decreasing Revenue
Revenue is down for the last 2 quarters, 20.09M → 13.54M (in $), with an average decrease of 32.6% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -2.74M → -11.50M (in $), with an average decrease of 319.3% per quarter

Aquestive Therapeutics Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$67.4M	↑ 0.77%
Net Income	$-61.4M	↑ 586.3%
Net Profit Margin	-91.02%	↓ 77.66%

	FY19	Y/Y Change
Revenue	$52.6M	↓ 21.98%
Net Income	$-72.7M	↑ 18.38%
Net Profit Margin	-138.11%	↓ 47.09%

	FY20	Y/Y Change
Revenue	$45.8M	↓ 12.85%
Net Income	$-65.4M	↓ 10.04%
Net Profit Margin	-142.56%	↓ 4.45%

	FY21	Y/Y Change
Revenue	$50.8M	↑ 10.87%
Net Income	$-90.0M	↑ 37.75%
Net Profit Margin	-177.12%	↓ 34.56%

	FY22	Y/Y Change
Revenue	$47.7M	↓ 6.2%
Net Income	$-60.2M	↓ 33.14%
Net Profit Margin	-126.26%	↑ 50.86%

	FY23	Y/Y Change
Revenue	$50.6M	↑ 6.09%
Net Income	$-7.9M	↓ 86.93%
Net Profit Margin	-15.56%	↑ 110.7%

	Q2 FY23	Q/Q Change
Revenue	$13.2M	↑ 18.92%
Net Income	$-5.8M	↓ 130.0%
Net Profit Margin	-43.74%	↓ 217.14%

	Q3 FY23	Q/Q Change
Revenue	$13.0M	↓ 1.8%
Net Income	$-2.0M	↓ 64.87%
Net Profit Margin	-15.65%	↑ 28.09%

	Q4 FY23	Q/Q Change
Revenue	$13.2M	↑ 1.57%
Net Income	$-8.1M	↑ 298.57%
Net Profit Margin	-61.42%	↓ 45.77%

	Q1 FY24	Q/Q Change
Revenue	$12.1M	↓ 8.73%
Net Income	$-12.8M	↑ 58.16%
Net Profit Margin	-106.43%	↓ 45.01%

	Q2 FY24	Q/Q Change
Revenue	$20.1M	↑ 66.76%
Net Income	$-2.7M	↓ 78.6%
Net Profit Margin	-13.66%	↑ 92.77%

	Q3 FY24	Q/Q Change
Revenue	$13.5M	↓ 32.62%
Net Income	$-11.5M	↑ 319.27%
Net Profit Margin	-84.99%	↓ 71.33%

	FY18	Y/Y Change
Profit	$46.4M	↓ 1.39%

	FY19	Y/Y Change
Profit	$32.2M	↓ 30.56%

	FY20	Y/Y Change
Profit	$32.9M	↑ 1.98%

	FY21	Y/Y Change
Profit	$35.8M	↑ 8.99%

	FY22	Y/Y Change
Profit	$28.3M	↓ 21.06%

	FY23	Y/Y Change
Profit	$29.8M	↑ 5.15%

	Q2 FY23	Q/Q Change
Profit	$6.6M	↑ 3.55%

	Q3 FY23	Q/Q Change
Profit	$8.2M	↑ 23.85%

	Q4 FY23	Q/Q Change
Profit	$8.5M	↑ 3.94%

	Q1 FY24	Q/Q Change
Profit	$7.7M	↓ 10.12%

	Q2 FY24	Q/Q Change
Profit	$15.6M	↑ 103.2%

	Q3 FY24	Q/Q Change
Profit	$9.1M	↓ 41.53%

	FY18	Y/Y Change
Operating Cash Flow	$-13.0M	↓ 323.06%
Investing Cash Flow	$-1.8M	↓ 11.8%
Financing Cash Flow	$58.0M	↑ 1214.79%

	FY19	Y/Y Change
Operating Cash Flow	$-60.2M	↑ 363.47%
Investing Cash Flow	$-663.0K	↓ 63.65%
Financing Cash Flow	$49.6M	↓ 14.53%

	FY20	Y/Y Change
Operating Cash Flow	$-45.5M	↓ 24.5%
Investing Cash Flow	$-517.0K	↓ 22.02%
Financing Cash Flow	$28.5M	↓ 42.63%

	FY21	Y/Y Change
Operating Cash Flow	$-33.0M	↓ 27.45%
Investing Cash Flow	$-913.0K	↑ 76.6%
Financing Cash Flow	$30.1M	↑ 5.81%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-7.9M	↓ 189.69%
Investing Cash Flow	$-826.0K	↑ 41200.0%
Financing Cash Flow	$4.3M	↓ 146.57%

Aquestive Therapeutics Technicals Summary

Sell

Neutral

Buy

Aquestive Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Aquestive Therapeutics Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Aquestive Therapeutics Inc	-17.4%	43.55%	57.52%	-12.96%	-39.04%
Neurocrine Biosciences Inc.	6.86%	-1.86%	2.19%	57.46%	23.23%
Haleon Plc Spon Ads	-1.55%	12.63%	13.84%	28.74%	28.74%
Zoetis Inc.	-7.07%	-6.88%	-16.03%	-27.63%	22.38%
Viatris Inc.	-4.52%	20.64%	7.79%	-13.36%	-23.81%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Aquestive Therapeutics Inc	NA	NA	NA	-0.42	0.0	-0.16	NA	-0.5
Neurocrine Biosciences Inc.	36.4	36.4	0.32	6.37	0.16	0.12	NA	26.87
Haleon Plc Spon Ads	28.91	28.91	1.72	0.34	0.07	0.04	0.02	1.82
Zoetis Inc.	30.57	30.57	2.52	5.88	0.47	0.15	0.01	11.59
Viatris Inc.	224.4	NA	0.08	2.69	-0.04	0.02	0.04	16.58

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Aquestive Therapeutics Inc	Buy	$324.6M	-39.04%	NA	-59.75%
Neurocrine Biosciences Inc.	Buy	$13.8B	23.23%	36.4	17.21%
Haleon Plc Spon Ads	Buy	$43.1B	28.74%	28.91	10.75%
Zoetis Inc.	Buy	$73.5B	22.38%	30.57	26.55%
Viatris Inc.	Hold	$14.9B	-23.81%	224.4	-5.87%

About Aquestive Therapeutics

aquestive therapeutics is a specialty pharmaceutical company that advances and commercializes medicines to solve critical healthcare problems and meaningfully improve people’s lives. our team asks questions and identifies issues others have not, and builds solutions that empower patients and their caregivers with better ways to manage complex diseases. our initial focus, supported by our current approved products and late stage pipeline, is to address immediate cns challenges.

Organization	Aquestive Therapeutics
Employees	135
CEO	Mr. Daniel Barber
Industry	Health Technology

Management People of Aquestive Therapeutics

Name	Title
Mr. Daniel Barber	CEO, President & Director
Mr. A. Ernest Toth Jr.	Chief Financial Officer
Ms. Lori J. Braender BSBA, Esq., J.D.	Chief Legal Officer, Chief Compliance Officer &Secretary
Ms. Cassie Jung	Chief Operating Officer
Mr. Alexander Mark Schobel	Chief Innovation & Technology Officer
Dr. Stephen Wargacki Ph.D.	Chief Science Officer
Ms. Sherry Korczynski	Senior Vice President of Sales & Marketing
Mr. Peter E. Boyd	Senior Vice President of Information Technology & Human Resources
Dr. Gary H. Slatko M.D., MBA	Chief Medical Officer
Dr. Carl N. Kraus M.D.	Chief Medical Officer

Important FAQs about investing in Aquestive Therapeutics from India :

What is Aquestive Therapeutics share price today?

Aquestive Therapeutics share price today stands at $3.67, Open: $3.60 ; Previous Close: $3.56 ; High: $3.78 ; Low: $3.56 ; 52 Week High: $6.23 ; 52 Week Low: $1.98. The stock opens at $3.60, after a previous close of $3.56. The stock reached a daily high of $3.78 and a low of $3.56, with a 52-week high of $6.23 and a 52-week low of $1.98.

Can Indians buy Aquestive Therapeutics shares?

Yes, Indians can invest in the Aquestive Therapeutics (AQST) from India.

With INDmoney, you can buy Aquestive Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Aquestive Therapeutics at zero transaction cost.

How can I buy Aquestive Therapeutics shares from India?

It is very easy to buy Aquestive Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Aquestive Therapeutics be purchased?

Yes, you can buy fractional shares of Aquestive Therapeutics with INDmoney app.

What are the documents required to start investing in Aquestive Therapeutics stocks?

To start investing in Aquestive Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.